WAT

Waters Corporation

Healthcare · $43.4B market cap

Verdict

Share price

$425.21

close of Oct 3, 2026

Fair value

$195.96

Sticker Price

Payback Price

$78.38

buy price

Overpriced

WAT is Overpriced: at $425.21 it trades 117% above its fair value of $195.96. Its buy price (Payback Price) is $78.38, 82% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth5.2% a year✗
Equity per share growth10.3% a year✓
Sales growth4.5% a year✗
Free cash flow growth3.9% a year✗
Return on invested capital18.1%✓

Follow WAT

Get notified when it reaches its buy price of $78.38. Free.

Create a free account

Superinvestors

8 of the investors we track hold WAT. In Q2 2026, 1 added and 4 trimmed. Who we track

Insider activity

Since Jun 24, 2026: no open-market purchases, 1 sale worth $1.4M and 4 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Waters Corporation

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like…

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works